Cargando…

Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441559/
https://www.ncbi.nlm.nih.gov/pubmed/37226191
http://dx.doi.org/10.1093/ecco-jcc/jjad082
_version_ 1785093400046862336
collection PubMed
description
format Online
Article
Text
id pubmed-10441559
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104415592023-08-22 Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study J Crohns Colitis Correction Oxford University Press 2023-05-24 /pmc/articles/PMC10441559/ /pubmed/37226191 http://dx.doi.org/10.1093/ecco-jcc/jjad082 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Correction
Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
title Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
title_full Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
title_fullStr Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
title_full_unstemmed Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
title_short Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
title_sort correction to: corticosteroid-sparing effects of filgotinib in moderately to severely active ulcerative colitis: data from the phase 2b/3 selection study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441559/
https://www.ncbi.nlm.nih.gov/pubmed/37226191
http://dx.doi.org/10.1093/ecco-jcc/jjad082